Results 1 to 10 of about 1,261,156 (366)

A disproportionality analysis of FDA adverse event reporting system events for misoprostol [PDF]

Scientific Reports
Misoprostol was originally used to treat gastric ulcers, and has been widely used in abortion, cervical maturation, induced labour and postpartum hemorrhage. But there are still many undetected adverse events (AEs).
Li Yang, Wenting Xu
doaj   +3 more sources

A Standardized Dataset of a Spontaneous Adverse Event Reporting System [PDF]

Healthcare, 2022
One of the largest spontaneous adverse events reporting databases in the world is the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS). Unfortunately, researchers face many obstacles in analyzing data from the FAERS database. One
M. A. Khaleel, A. Khan, S. Ghadzi, A. Adnan, Qasem M A Abdallah   +4 more
semanticscholar   +3 more sources

Adverse event reporting systems and safer healthcare [PDF]

Quality and Safety in Health Care, 2009
At the heart of improvement and safety in healthcare is the now-familiar tenet that was espoused decades ago by Demming and paraphrased by Berwick.1 Need we repeat it again? Every defect should lead to improvement processes that make care safer. It is time to deliver on the promise of reporting systems in patient safety.
James B Battles, David Stevens
openalex   +4 more sources

Ocular Complications after COVID-19 Vaccination, Vaccine Adverse Event Reporting System

Vaccines, 2022
In December 2020, the U.S. Food and Drug Administration licensed COVID-19 vaccines for emergency use authorization. We investigated the ocular adverse event reports in patients reported to the Vaccine Adverse Event Reporting System (VAERS) following ...
Cyril N. A. Nyankerh, Akosua K. Boateng, Mary Appah   +2 more
doaj   +2 more sources

Military Healthcare Providers Reporting of Adverse Events Following Immunizations to the Vaccine Adverse Event Reporting System [PDF]

Military Medicine, 2014
We studied military health care provider (HCP) practices regarding reporting of adverse events following immunization (AEFI).A convenience sample of HCP was surveyed to assess familiarity with Vaccine Adverse Event Reporting System (VAERS), AEFI they were likely to report, methods used and preferred for reporting, and perceived barriers to reporting ...
Rongxia Li, Michael M. McNeil, Susanne Pickering, Michael R. Pemberton, Laurie Duran, Limone Collins, Michael R. Nelson, Renata J.M. Engler   +7 more
openalex   +3 more sources

Assessing taxane-associated adverse events using the FDA adverse event reporting system database

Chinese Medical Journal, 2021
. Background:. Taxanes are an essential class of antineoplastic agents used to treat various cancers and are a fundamental cause of hypersensitivity reactions. In addition, other adverse events, such as bone marrow toxicity and peripheral neuropathy, can
Dong-Hui Lao, Ye Chen, Jun Fan, Jian-Zhong Zhang, Peng Lyu.   +4 more
doaj   +3 more sources

Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database [PDF]

Frontiers in Pharmacology
BackgroundFaricimab is the first and only bispecific antibody approved by the U.S. Food and Drug Administration (FDA) for intravitreal injection. Given its increasingly widespread use in retinal vascular diseases, understanding its adverse events (AEs ...
Chang-Zhu He, Qin Qiu, Song-Jie Lu, Fu-Li Xue, Jun-Qiao Liu, Yu He   +5 more
doaj   +2 more sources

Status and Problems of Adverse Event Reporting Systems in Korean Hospitals [PDF]

Healthcare Informatics Research, 2010
ObjectivesThis study identifies the current status and problems of adverse event reporting system in Korean hospitals. The data obtained from this study will be used to raise international awareness and enable collaborative researches on patient safety ...
Jeongeun Kim, Sukwha Kim, Yoenyi Jung, Eun-Kyung Kim   +3 more
doaj   +5 more sources

Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database

Thrombosis Journal, 2022
Background Tigecycline has broad-spectrum anti-bacterial activity and often used for critically ill patients with complicated infections. Only a few clinical studies have reported the coagulation disorder induced by tigecycline. The aim of this study was
Mingxing Guo, Jinwei Liang, Dandan Li, Ying Zhao, Wanyi Xu, Lei Wang, Xiangli Cui   +6 more
doaj   +2 more sources

Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system

Frontiers in Public Health, 2022
BackgroundSemaglutide was approved for treatment of type 2 diabetes mellitus (T2DM) and chronic weight management in obesity or overweight adults. However, real-world data regarding its long-term gastrointestinal safety and tolerability in large sample ...
Yamin Shu, Xucheng He, Pan Wu, Yanxin Liu, Yufeng Ding, Qilin Zhang   +5 more
doaj   +2 more sources